Abstract
Large population studies have shown that living at higher altitudes, which lowers ambient oxygen exposure, is associated with reduced cardiovascular disease mortality. However, hypoxia has also been reported to promote atherosclerosis by worsening lipid metabolism and inflammation. We sought to address these disparate reports by reducing the ambient oxygen exposure of ApoE−/− mice. We observed that long-term adaptation to 10 % O2 (equivalent to oxygen content at ∼5000 m), compared to 21 % O2 (room air at sea level), resulted in a marked decrease in aortic atherosclerosis in ApoE−/− mice. This effect was associated with increased expression of the anti-inflammatory cytokine interleukin-10 (IL-10), known to be anti-atherogenic and regulated by hypoxia-inducible transcription factor-1α (HIF-1α). Supporting these observations, ApoE−/− mice that were deficient in IL-10 (IL10−/− ApoE−/− double knockout) failed to show reduced atherosclerosis in 10 % oxygen. Our study reveals a specific mechanism that can help explain the decreased prevalence of ischemic heart disease in populations living at high altitudes and identifies ambient oxygen exposure as a potential factor that could be modulated to alter pathogenesis.
Key messages
-
Chronic low ambient oxygen exposure decreases atherosclerosis in mice.
-
Anti-inflammatory cytokine IL-10 levels are increased by low ambient O2.
-
This is consistent with the established role of HIF-1α in IL10 transactivation.
-
Absence of IL-10 results in the loss of the anti-atherosclerosis effect of low O2.
-
This mechanism may contribute to decreased atherosclerosis at high altitudes.
Similar content being viewed by others
References
Mortimer EA Jr, Monson RR, MacMahon B (1977) Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 296:581–585
Faeh D, Gutzwiller F, Bopp M (2009) Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 120:495–501
Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, Mori T, Sohmiya K, Kitaura Y, Okada Y et al (2005) Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res 28:837–845
Jun J, Reinke C, Bedja D, Berkowitz D, Bevans-Fonti S, Li J, Barouch LA, Gabrielson K, Polotsky VY (2010) Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 209:381–386
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Palazon A, Goldrath AW, Nizet V, Johnson RS (2014) HIF transcription factors, inflammation, and immunity. Immunity 41:518–528
Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V et al (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645–657
Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P, Ohta A, Lentsch AB, Lukashev D, Sitkovsky MV (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2, e853. doi:10.1371/journal.pone.0000853
Kleemann R, Zadelaar S, Kooistra T (2008) Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79:360–376
Ben-Shoshan J, Afek A, Maysel-Auslender S, Barzelay A, Rubinstein A, Keren G, George J (2009) HIF-1alpha overexpression and experimental murine atherosclerosis. Arterioscler Thromb Vasc Biol 29:665–670
Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5:712–721
Wang PY, Ma W, Park JY, Celi FS, Arena R, Choi JW, Ali QA, Tripodi DJ, Zhuang J, Lago CU et al (2013) Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 368:1027–1032
Kang JG, Amar MJ, Remaley AT, Kwon J, Blackshear PJ, Wang PY, Hwang PM (2011) Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation. J Immunol 187:2696–2701
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274
Sung HJ, Ma W, Starost MF, Lago CU, Lim PK, Sack MN, Kang JG, Wang PY, Hwang PM (2011) Ambient oxygen promotes tumorigenesis. PLoS One 6:e19785
Abud EM, Maylor J, Undem C, Punjabi A, Zaiman AL, Myers AC, Sylvester JT, Semenza GL, Shimoda LA (2012) Digoxin inhibits development of hypoxic pulmonary hypertension in mice. Proc Natl Acad Sci U S A 109:1239–1244
Patino WD, Kang JG, Matoba S, Mian OY, Gochuico BR, Hwang PM (2006) Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin. Circ Res 98:1282–1289
Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529–32537
Maganto-Garcia E, Tarrio M, Lichtman AH (2012) Mouse models of atherosclerosis. Current protocols in immunology / edited by John E Coligan [et al.] Chapter 15: Unit 15 24 11–23. doi 10.1002/0471142735.im1524s96
West JB (2002) Highest permanent human habitation. High Alt Med Biol 3:401–407
Daugherty A (2002) Mouse models of atherosclerosis. Am J Med Sci 323:3–10
Caligiuri G, Nicoletti A, Zhou X, Tornberg I, Hansson GK (1999) Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 145:301–308
Jiang H, Chess L (2006) Regulation of immune responses by T cells. N Engl J Med 354:1166–1176
Cai Z, Luo W, Zhan H, Semenza GL (2013) Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci U S A 110:17462–17467
Han X, Boisvert WA (2015) Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 113:505–512
McAleer JP, Vella AT (2008) Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Crit Rev Immunol 28:281–299
Atkuri KR, Herzenberg LA, Niemi AK, Cowan T (2007) Importance of culturing primary lymphocytes at physiological oxygen levels. Proc Natl Acad Sci U S A 104:4547–4552
Ali K, Middleton M, Pure E, Rader DJ (2005) Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 97:922–927
Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170–181
Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, Nicoletti A (2003) Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9:10–17
Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C et al (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17–e24
Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665
Marsch E, Theelen TL, Demandt JA, Jeurissen M, van Gink M, Verjans R, Janssen A, Cleutjens JP, Meex SJ, Donners MM et al (2014) Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis. Arterioscler Thromb Vasc Biol 34:2545–2553
Getz GS, Reardon CA (2015) Use of mouse models in atherosclerosis research. Methods Mol Biol 1339:1–16
Meehan RT (1987) Immune suppression at high altitude. Ann Emerg Med 16:974–979
Sitkovsky MV (2009) T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol 30:102–108
Lu KY, Ching LC, Su KH, Yu YB, Kou YR, Hsiao SH, Huang YC, Chen CY, Cheng LC, Pan CC et al (2010) Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation 121:1828–1837
Karagiannidis C, Hense G, Rueckert B, Mantel PY, Ichters B, Blaser K, Menz G, Schmidt-Weber CB (2006) High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation. Scand J Immunol 63:304–310
Saeed O, Bhatia V, Formica P, Browne A, Aldrich TK, Shin JJ, Maybaum S (2012) Improved exercise performance and skeletal muscle strength after simulated altitude exposure: a novel approach for patients with chronic heart failure. J Card Fail 18:387–391
Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ et al (2015) Air versus oxygen in ST-segment elevation myocardial infarction. Circulation. doi:10.1161/CIRCULATIONAHA.114.014494
Shehade H, Acolty V, Moser M, Oldenhove G (2015) Cutting edge: hypoxia-inducible factor 1 negatively regulates Th1 function. J Immunol 195:1372–1376
Vuillefroy de Silly R, Ducimetiere L, Yacoub Maroun C, Dietrich PY, Derouazi M, Walker PR (2015) Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol 45:2263–2275
Acknowledgments
We wish to thank the members of our laboratory Cory U. Lago, William M. Kamp, Jerry J. Li, and Jie Zhuang for the helpful assistance and critical comments. We also thank the mouse facility staff for the hypoxia chamber maintenance and Elias Gonzalez and Bruce Bishop for the technical assistance.
Author contributions
Authors responsible for concept and design were JGK, HS, JYK, PYW, and PH. JGK, HS, MJA, MP, MDA, AN, DS, JC, and JP contributed data. JGK, AR, AN, JP, JC, PYW, and PH were responsible in the analysis and interpretation of data. JGK, PYW, and PH drafted the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Study approval
All mice were maintained and handled in accordance with the NHLBI Animal Care and Use Committee. All human samples were obtained from healthy volunteers after informed consent as approved by the NHLBI Institutional Review Board.
Conflict of interests
The authors declare that they have no competing interests.
Sources of funding
Research supported by the Division of Intramural Research, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 384 kb)
Rights and permissions
About this article
Cite this article
Kang, JG., Sung, H.J., Amar, M.J. et al. Low ambient oxygen prevents atherosclerosis. J Mol Med 94, 277–286 (2016). https://doi.org/10.1007/s00109-016-1386-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-016-1386-3